Pfizer: Asthma trials
The registry lists 24 Asthma studies with Pfizer as lead sponsor. 4 are open to participants now and 6 have results posted.
Phase 1 8Phase 2 10Phase 3 3No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe AsthmaRecruitingNCT07869043Phase 3
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe AsthmaRecruitingNCT07772921Phase 3
- A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate AsthmaRecruitingNCT07660731Phase 1
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaRecruitingNCT06977581Phase 2
- Safety and Efficacy Active Drug vs. Placebo in Subjects With AsthmaTerminatedNCT04987944Phase 1Results posted
- An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled AsthmaTerminatedNCT02219048Phase 2Results posted
- PF-04191834 Single Dose Bronchodilatory Study In Asthma.CompletedNCT00723021Phase 2Results posted
- Study Evaluating the Effect of IMA-638 in Subjects With Persistent AsthmaCompletedNCT00425061Phase 2Results posted
- Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic AsthmaCompletedNCT00410280Phase 2Results posted
- A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With AsthmaCompletedNCT00139659Phase 3Results posted
- A Study of ARRY-502 in Patients With Persistent AsthmaCompletedNCT01561690Phase 2
- A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen ChallengeWithdrawnNCT01299467Phase 1
- To Test The Relative Bioavailability Of PF-04191834 When Dosed As An Immediate Release Tablet Compared With Solution Following Single And Multiple DosingCompletedNCT01064804
- A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355CompletedNCT01043276Phase 1
- Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung ObstructionCompletedNCT01033669
- A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian PatientsWithdrawnNCT00971893
- A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic SubjectsCompletedNCT00877539Phase 1
- A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic SubjectsCompletedNCT00856687Phase 1
- A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic SubjectsWithdrawnNCT00830427Phase 2
- Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild AsthmaCompletedNCT00725582Phase 1
- A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.CompletedNCT00468975Phase 2
- Study Evaluating IMA-638 in AsthmaCompletedNCT00339872Phase 1
- A Study of the Safety and Efficacy of Tofimilast in Adult AsthmaticsCompletedNCT00150397Phase 2
- Study Evaluating Etanercept in Moderate to Severe AsthmaCompletedNCT00141791Phase 2